|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
ELV048866032 |
| 003 |
DE-627 |
| 005 |
20230624150911.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
200108s2020 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.pcd.2019.03.008
|2 doi
|
| 028 |
5 |
2 |
|a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000848.pica
|
| 035 |
|
|
|a (DE-627)ELV048866032
|
| 035 |
|
|
|a (ELSEVIER)S1751-9918(18)30455-8
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 082 |
0 |
4 |
|a 630
|q VZ
|
| 082 |
0 |
4 |
|a 640
|q VZ
|
| 082 |
0 |
4 |
|a 590
|q VZ
|
| 082 |
0 |
4 |
|a 610
|q VZ
|
| 082 |
0 |
4 |
|a 600
|q VZ
|
| 084 |
|
|
|a 50.70
|2 bkl
|
| 100 |
1 |
|
|a Amin, Kawa
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Levels of cytokines and GADA in type I and II diabetic patients
|
| 264 |
|
1 |
|c 2020
|
| 300 |
|
|
|a 7
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 520 |
|
|
|a • The importance of pro-inflammatory cytokine interplay which leads to the development of diabetes. • IL-3, IL-1b, INF-g suggest that during diabetic disease progression pro-inflammatory cytokines play a crucial role. • In the treatment of diabetic anti-inflammatory actions potentially relevant in the therapeutic approach to this complication.
|
| 650 |
|
7 |
|a IFN-γ
|2 Elsevier
|
| 650 |
|
7 |
|a GADA
|2 Elsevier
|
| 650 |
|
7 |
|a IL-3
|2 Elsevier
|
| 650 |
|
7 |
|a IL-1β
|2 Elsevier
|
| 650 |
|
7 |
|a Immune system
|2 Elsevier
|
| 700 |
1 |
|
|a Qadr, Shnyar Hamid
|4 oth
|
| 700 |
1 |
|
|a Hassan Hussein, Ridha
|4 oth
|
| 700 |
1 |
|
|a Ali, Kosar Muhammad
|4 oth
|
| 700 |
1 |
|
|a Rahman, Heshu Sulaiman
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|n Elsevier
|a David, Lauren A. ELSEVIER
|t A pilot randomized controlled trial examining the feasibility, acceptability, and efficacy of Adapted Motivational Interviewing for post-operative bariatric surgery patients
|d 2016
|g Amsterdam [u.a.]
|w (DE-627)ELV024210129
|
| 773 |
1 |
8 |
|g volume:14
|g year:2020
|g number:1
|g pages:61-67
|g extent:7
|
| 856 |
4 |
0 |
|u https://doi.org/10.1016/j.pcd.2019.03.008
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_U
|
| 912 |
|
|
|a GBV_ELV
|
| 912 |
|
|
|a SYSFLAG_U
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_60
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_227
|
| 912 |
|
|
|a GBV_ILN_350
|
| 936 |
b |
k |
|a 50.70
|j Energie: Allgemeines
|q VZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 14
|j 2020
|e 1
|h 61-67
|g 7
|